MDR1 inhibition: less resistance or less relevance?
- 31 December 2002
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (18), 2337-2340
- https://doi.org/10.1016/s0959-8049(02)00490-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- ApoptosisCell, 2002
- Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyBlood, 2001
- Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistanceSeminars in Cell & Developmental Biology, 2001
- The multidrug resistance protein familyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- In VivoModel Systems in P-Glycoprotein-Mediated Multidrug ResistanceCritical Reviews in Clinical Laboratory Sciences, 1998
- Modulation and prevention of multidrug resistance by inhibitors of P-glycoproteinCancer Chemotherapy and Pharmacology, 1997
- P-Glycoproteins and Multidrug ResistanceAnnual Review of Pharmacology and Toxicology, 1996
- P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell linesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- Glutathione S-transferase in chemotherapy resistance and in carcinogenesisBiochemistry and Cell Biology, 1992